8 studies found for:    "microbicide" AND "gel" | Open Studies | HIV
Show Display Options
Download search resultsDownload the search results for:
"microbicide" AND "gel" | Open Studies | HIV (8 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosage Forms
Condition: HIV
Interventions: Other: HEC Placebo gel;   Other: Placebo Intravaginal Ring;   Other: Placebo Vaginal Film;   Other: Placebo Vaginal Insert
2 Recruiting The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended Pregnancy
Conditions: HIV;   Contraception
Interventions: Other: HEC Placebo Gel;   Other: Placebo Vaginal Insert;   Other: Placebo Vaginal Film;   Other: Placebo Intravaginal ring (IVR)
3 Recruiting Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel in HIV-1 Seronegative Adults
Condition: HIV/AIDS
Intervention: Drug: Maraviroc 300 mg tablet (PO) and Maraviroc 1% gel (PR and PV)
4 Unknown  An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots
Condition: HIV Infections
Intervention: Drug: HEC placebo gel
5 Not yet recruiting Developing Rectal USPE Measures for Suppositories (Project DRUM-S)
Condition: Microbicide Delivery System Perceptibility and Acceptability
Intervention:
6 Recruiting PrEP, Lube, and the Rectal Mucosa in MSM at Risk of HIV
Condition: HIV
Interventions: Drug: Truvada;   Device: Gel lubricant
7 Recruiting Optimization of the ex Vivo Challenge: Reproductive Infections and Contraception
Condition: HIV
Intervention: Other: no intervention
8 Unknown  Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra
Conditions: Children With Confirmed HIV Infection;   Receiving ART Regimen Containing 2 NRTIs + LPV/RTV at Standard Dose;   Successfully Completed TB Treatment in the Past 2 to 6 Weeks of Enrollment
Intervention: Drug: Mycobutin

Indicates status has not been verified in more than two years